AngioDynamics (ANGO) Reports In-Line Q2 EPS, Miss on Revenues; Lowers FY18 Revenue Guidance Below Consensus

AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $86.7 million versus the consensus estimate of $88.42 million.

GUIDANCE:

AngioDynamics sees FY2018 EPS of $0.64-$0.68, versus the consensus of $0.66. AngioDynamics sees FY2018 revenue of $345-350 million, versus the consensus of $353.33 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance